These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 8395300

  • 1. Inhibition by nitric oxide-donors of human polymorphonuclear leucocyte functions.
    Moilanen E, Vuorinen P, Kankaanranta H, Metsä-Ketelä T, Vapaatalo H.
    Br J Pharmacol; 1993 Jul; 109(3):852-8. PubMed ID: 8395300
    [Abstract] [Full Text] [Related]

  • 2. Investigation of the role of nitric oxide and cyclic GMP in both the activation and inhibition of human neutrophils.
    Wanikiat P, Woodward DF, Armstrong RA.
    Br J Pharmacol; 1997 Nov; 122(6):1135-45. PubMed ID: 9401778
    [Abstract] [Full Text] [Related]

  • 3. 3-Morpholino-sydnonimine-induced suppression of human neutrophil degranulation is not mediated by cyclic GMP, nitric oxide or peroxynitrite: inhibition of the increase in intracellular free calcium concentration by N-morpholino-iminoacetonitrile, a metabolite of 3-morpholino-sydnonimine.
    Kankaanranta H, Knowles RG, Vuorinen P, Kosonen O, Holm P, Moilanen E.
    Mol Pharmacol; 1997 May; 51(5):882-8. PubMed ID: 9145927
    [Abstract] [Full Text] [Related]

  • 4. The effect of nitric oxide donors on insulin secretion, cyclic GMP and cyclic AMP in rat islets of Langerhans and the insulin-secreting cell lines HIT-T15 and RINm5F.
    Cunningham JM, Mabley JG, Delaney CA, Green IC.
    Mol Cell Endocrinol; 1994 Jun; 102(1-2):23-9. PubMed ID: 7926270
    [Abstract] [Full Text] [Related]

  • 5. Radical releasing properties of nitric oxide donors GEA 3162, SIN-1 and S-nitroso-N-acetylpenicillamine.
    Holm P, Kankaanranta H, Metsä-Ketelä T, Moilanen E.
    Eur J Pharmacol; 1998 Apr 03; 346(1):97-102. PubMed ID: 9617758
    [Abstract] [Full Text] [Related]

  • 6. Nitric oxide donors induce extrusion of cyclic GMP from isolated human blood platelets by a mechanism which may be modulated by prostaglandins.
    Radziszewski W, Chopra M, Zembowicz A, Gryglewski R, Ignarro LJ, Chaudhuri G.
    Int J Cardiol; 1995 Oct 03; 51(3):211-20. PubMed ID: 8586470
    [Abstract] [Full Text] [Related]

  • 7. The effects of the nitric oxide donors molsidomine and SIN-I on human polymorphonuclear leucocyte function in vitro and ex vivo.
    Darius H, Grodzinska L, Meyer J.
    Eur J Clin Pharmacol; 1992 Oct 03; 43(6):629-33. PubMed ID: 1337322
    [Abstract] [Full Text] [Related]

  • 8. Role of cyclic GMP on inhibition by nitric oxide donors of human eosinophil chemotaxis in vitro.
    Thomazzi SM, Moreira J, Marcondes S, De Nucci G, Antunes E.
    Br J Pharmacol; 2004 Feb 03; 141(4):653-60. PubMed ID: 14744805
    [Abstract] [Full Text] [Related]

  • 9. Cyclic GMP mediates SIN-1-induced inhibition of human polymorphonuclear leukocytes.
    Schröder H, Ney P, Woditsch I, Schrör K.
    Eur J Pharmacol; 1990 Jul 03; 182(2):211-8. PubMed ID: 1697805
    [Abstract] [Full Text] [Related]

  • 10. Evidence that different mechanisms underlie smooth muscle relaxation to nitric oxide and nitric oxide donors in the rabbit isolated carotid artery.
    Plane F, Wiley KE, Jeremy JY, Cohen RA, Garland CJ.
    Br J Pharmacol; 1998 Apr 03; 123(7):1351-8. PubMed ID: 9579730
    [Abstract] [Full Text] [Related]

  • 11. Nitric oxide-donating properties of mesoionic 3-aryl substituted oxatriazole-5-imine derivatives.
    Kankaanranta H, Rydell E, Petersson AS, Holm P, Moilanen E, Corell T, Karup G, Vuorinen P, Pedersen SB, Wennmalm A, Metsä-Ketelä T.
    Br J Pharmacol; 1996 Feb 03; 117(3):401-406. PubMed ID: 8821526
    [Abstract] [Full Text] [Related]

  • 12. Exogenous nitric oxide elicits chemotaxis of neutrophils in vitro.
    Beauvais F, Michel L, Dubertret L.
    J Cell Physiol; 1995 Dec 03; 165(3):610-4. PubMed ID: 7593240
    [Abstract] [Full Text] [Related]

  • 13. Inhibitory effects of mesoionic 3-aryl substituted oxatriazole-5-imine derivatives on vascular smooth muscle cell mitogenesis and proliferation in vitro.
    Lähteenmäki T, Sievi E, Vapaatalo H.
    Br J Pharmacol; 1998 Sep 03; 125(2):402-8. PubMed ID: 9786515
    [Abstract] [Full Text] [Related]

  • 14. Mechanisms of relaxations of bovine isolated bronchioles by the nitric oxide donor, GEA 3175.
    Hernández M, Elmedal B, Mulvany MJ, Simonsen U.
    Br J Pharmacol; 1998 Mar 03; 123(5):895-905. PubMed ID: 9535018
    [Abstract] [Full Text] [Related]

  • 15. Positive and negative inotropic effects of NO donors in atrial and ventricular fibres of the frog heart.
    Chesnais JM, Fischmeister R, Méry PF.
    J Physiol; 1999 Jul 15; 518 ( Pt 2)(Pt 2):449-61. PubMed ID: 10381591
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of human lymphocyte proliferation by nitric oxide-releasing oxatriazole derivatives.
    Kosonen O, Kankaanranta H, Vuorinen P, Moilanen E.
    Eur J Pharmacol; 1997 Oct 15; 337(1):55-61. PubMed ID: 9389381
    [Abstract] [Full Text] [Related]

  • 17. Effects of NO-donors, SIN-1 and GEA 3175 on prostacyclin and cGMP synthesis in cultured rat endothelial cells.
    Alanko J, Sievi E, Lähteenmäki T, Mucha I, Riutta A, Vapaatalo H.
    Agents Actions Suppl; 1995 Oct 15; 45():195-9. PubMed ID: 7717180
    [Abstract] [Full Text] [Related]

  • 18. Nitric oxide donors as generators and scavengers of superoxide anions.
    Robak J, Gryglewski RJ.
    Pol J Pharmacol; 1993 Oct 15; 45(1):51-8. PubMed ID: 8401759
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of beta- but not alpha 1-mediated adrenergic responses in isolated hearts and cardiomyocytes by nitric oxide and 8-bromo cyclic GMP.
    Ebihara Y, Karmazyn M.
    Cardiovasc Res; 1996 Sep 15; 32(3):622-9. PubMed ID: 8881523
    [Abstract] [Full Text] [Related]

  • 20. Effects of Trolox C and SIN-1 on arachidonic acid metabolism and on cyclic GMP formation in leukocytes.
    Riutta A, Alanko J, Mucha I, Vapaatalo H.
    Eur J Pharmacol; 1994 Sep 12; 262(3):217-22. PubMed ID: 7813586
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.